However, our results do not demonstrate a correlation between expression of BARD1 β and patho-clinical features in neuroblastoma and lack of BARD1 β (but not BARD1 FL) did not correlate with more favourable phenotype. The gene discussed is BARD1; the disease is neuroblastoma.